Forlong Biotechnology
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer
Funding history
1 round- $17.5M
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer